Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.057 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |